ARCHIVES

NCI Moves To Suspend Researcher Amid Charges Contractor Made Mortgage And Other Payments

This article is from The Cancer Letter archive.

Vol. 16 No. 18 | May 4, 1990

Download PDF Visit The Full Archive

Related Articles

Patient Satisfaction Was Crucial In ODAC Review Of Panretin

November 27, 1998

Mouse Strains For Retrovirus Research Available From NCU

March 23, 1984

Center Directors To Hear “Creative” Approach to Funding Cancer Control

February 25, 1983

New Technology May Enable Therapy Tailored To Patient’s Predicted Response

April 26, 2002

After Year-Long Review, Varmus Removes “Reasonable Pricing” Clause From CRADA

April 14, 1995

NeoPharm To Begin Phase III Trial For Glioblastoma

December 26, 2003